TY - JOUR
T1 - Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci
AU - The Consortium of Investigators of Modifiers of BRCA1/2
AU - The Ovarian Cancer Association Consortium
AU - Coetzee, Simon G.
AU - Shen, Howard C.
AU - Hazelett, Dennis J.
AU - Lawrenson, Kate
AU - Kuchenbaecker, Karoline
AU - Tyrer, Jonathan
AU - Rhie, Suhn K.
AU - Levanon, Keren
AU - Karst, Alison
AU - Drapkin, Ronny
AU - Ramus, Susan J.
AU - Couch, Fergus J.
AU - Offit, Kenneth
AU - Chenevix-Trench, Georgia
AU - Monteiro, Alvaro N.A.
AU - Antoniou, Antonis
AU - Freedman, Matthew
AU - Coetzee, Gerhard A.
AU - Pharoah, Paul D.P.
AU - Noushmehr, Houtan
AU - Gayther, Simon A.
AU - Anton-Culver, Hoda
AU - Antonenkova, Natalia
AU - Baker, Helen
AU - Bandera, Elisa V.
AU - Bean, Yukie
AU - Beckmann, Matthias W.
AU - Berchuck, Andrew
AU - Bisogna, Maria
AU - Bjorge, Line
AU - Bogdanova, Natalia
AU - Brinton, Louise A.
AU - Brooks-Wilson, Angela
AU - Bruinsma, Fiona
AU - Butzow, Ralf
AU - Campbell, Ian G.
AU - Carty, Karen
AU - Chang-Claude, Jenny
AU - Chen, Ann
AU - Chen, Zhihua
AU - Cook, Linda S.
AU - Cramer, Daniel W.
AU - Cunningham, Julie M.
AU - Cybulski, Cezary
AU - Dansonka-Mieszkowska, Agnieszka
AU - Dennis, Joe
AU - Dicks, Ed
AU - Doherty, Jennifer A.
AU - Dörk, Thilo
AU - Goode, Ellen L.
N1 - Publisher Copyright:
© The Author 2015. Published by Oxford University Press. All rights reserved.
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Understanding the regulatory landscape of the human genome is a central question in complex trait genetics. Most singlenucleotide polymorphisms (SNPs) associated with cancer risk lie in non-protein-coding regions, implicating regulatory DNA elements as functional targets of susceptibility variants. Here, we describe genome-wide annotation of regions of open chromatin and histone modification in fallopian tube and ovarian surface epithelial cells (FTSECs, OSECs), the debated cellular origins of high-grade serous ovarian cancers (HGSOCs) and in endometriosis epithelial cells (EECs), the likely precursor of clear cell ovarian carcinomas (CCOCs). The regulatory architecture of these cell types was compared with normal human mammary epithelial cells and LNCaP prostate cancer cells. We observed similar positional patterns of global enhancer signatures across the three different ovarian cancer precursor cell types, and evidence of tissue-specific regulatory signatures compared to nongynecological cell types. We found significant enrichment for risk-associated SNPs intersecting regulatory biofeatures at 17 known HGSOC susceptibility loci in FTSECs (P = 3.8 × 10-30), OSECs (P = 2.4 × 10-23) and HMECs (P = 6.7 × 10-15) but not for EECs (P = 0.45) or LNCaP cells (P = 0.88). Hierarchical clustering of risk SNPs conditioned on the six different cell types indicates FTSECs and OSECs are highly related (96% of samples using multi-scale bootstrapping) suggesting both cell types may be precursors of HGSOC. These data represent the first description of regulatory catalogues of normal precursor cells for different ovarian cancer subtypes, and provide unique insights into the tissue specific regulatory variation with respect to the likely functional targets of germline genetic susceptibility variants for ovarian cancer.
AB - Understanding the regulatory landscape of the human genome is a central question in complex trait genetics. Most singlenucleotide polymorphisms (SNPs) associated with cancer risk lie in non-protein-coding regions, implicating regulatory DNA elements as functional targets of susceptibility variants. Here, we describe genome-wide annotation of regions of open chromatin and histone modification in fallopian tube and ovarian surface epithelial cells (FTSECs, OSECs), the debated cellular origins of high-grade serous ovarian cancers (HGSOCs) and in endometriosis epithelial cells (EECs), the likely precursor of clear cell ovarian carcinomas (CCOCs). The regulatory architecture of these cell types was compared with normal human mammary epithelial cells and LNCaP prostate cancer cells. We observed similar positional patterns of global enhancer signatures across the three different ovarian cancer precursor cell types, and evidence of tissue-specific regulatory signatures compared to nongynecological cell types. We found significant enrichment for risk-associated SNPs intersecting regulatory biofeatures at 17 known HGSOC susceptibility loci in FTSECs (P = 3.8 × 10-30), OSECs (P = 2.4 × 10-23) and HMECs (P = 6.7 × 10-15) but not for EECs (P = 0.45) or LNCaP cells (P = 0.88). Hierarchical clustering of risk SNPs conditioned on the six different cell types indicates FTSECs and OSECs are highly related (96% of samples using multi-scale bootstrapping) suggesting both cell types may be precursors of HGSOC. These data represent the first description of regulatory catalogues of normal precursor cells for different ovarian cancer subtypes, and provide unique insights into the tissue specific regulatory variation with respect to the likely functional targets of germline genetic susceptibility variants for ovarian cancer.
UR - http://www.scopus.com/inward/record.url?scp=84936771937&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84936771937&partnerID=8YFLogxK
U2 - 10.1093/hmg/ddv101
DO - 10.1093/hmg/ddv101
M3 - Article
C2 - 25804953
AN - SCOPUS:84936771937
SN - 0964-6906
VL - 24
SP - 3595
EP - 3607
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 13
ER -